BACKGROUND/OBJECTIVES: There are several biomarkers for measuring iron deficiency (ID) in pregnancy, but the prevalence of ID and its association with inflammation and adverse pregnancy outcomes is inconclusive. The aim of this work was to describe the prevalence and determinants of first trimester ID and associations with pregnancy and birth outcomes. SUBJECTS/METHODS: A record-linkage cohort study of archived serum samples of women attending first trimester screening and birth and hospital data to ascertain maternal characteristics and pregnancy outcomes. Sera were analysed for iron stores (ferritin; μg/l), lack of iron in the tissues (soluble transferrin receptor (sTfR); nmol/l) and inflammatory (C-reactive protein (CRP); mg/dl) biomarkers. Total body iron (TBI) was calculated from serum ferritin (SF) and sTfR concentrations. Multivariate logistic regression analysed risk factors and pregnancy outcomes associated with ID using the definitions: SF o12 μg/l, TfR ⩾ 21.0 nmol/l, and TBI o0 mg/kg. RESULTS: Of the 4420 women, the prevalence of ID based on ferritin, sTfR and TBI was 19.6, 15.3 and 15.7%, respectively. Risk factors of ID varied depending on which iron parameter was used and included maternal age o25 years, multiparity, socioeconomic disadvantage, high maternal body weight and inflammation. ID, defined by SF and TBI but not TfR, was associated with reduced risk of gestational diabetes mellitus (GDM). ID defined using TBI only was associated with increased risk of large-for-gestation-age (LGA) infants. CONCLUSIONS: Nearly one in five Australian women begin pregnancy with ID. Further investigation of excess maternal weight and inflammation in the relationships between ID and GDM and LGA infants is needed.
INTRODUCTION
It is well established worldwide that women are at increased risk of iron deficiency (ID) during pregnancy. 1 Pregnant women with serum ferritin (SF) concentrations o 12 μg/l are classified as ID and having depleted iron stores. 2 SF is maximum at 12-16 weeks of gestation and then falls with advancing gestation from haemodilution and mobilization of iron stores. 3 Because of these normal physiological changes in SF concentration in later pregnancy, it has been suggested that the best time to detect maternal ID is in early pregnancy. 1 There is, however, an inherent difficulty in interpreting SF concentrations because ferritin takes part in the systemic acute phase response and can increase markedly in the presence of acute or chronic infection. 4 To aid the interpretation of ferritin concentration, concurrent measurement of an acute phase response protein, which is most commonly C-reactive protein (CRP), is recommended. 2 Measurement of circulating soluble transferrin receptor (sTfR) concentrations are also reported to be useful for defining ID because studies have found that sTfR may not be affected by infection 2, 5 or may be affected but to a lesser degree than SF. 6 sTfR suffers from a lack of standardization of the method and significant variation in the references ranges used. 7 Another method proposed for evaluating iron status within a population is the estimation of total body iron (TBI) on the basis of the ratio of sTfR to SF. 8 There are limited data on the prevalence of ID using these multiple iron indices from large, population-based studies. 9 Although there is some evidence that maternal ID is associated with increased risk of preterm delivery 10 and low birth weight, 11 reviews and meta-analyses are inconclusive as to whether iron supplementation in pregnancy improves clinical outcomes for the mother or infant. 9, 12, 13 Therefore, the aims of this study are to examine the prevalence of ID in women in the first trimester of pregnancy using various measures of iron status of SF, sTfR, TBI and CRP and assess risk factors of ID and associations between ID and pregnancy and birth outcomes.
SUBJECTS AND METHODS

Study population
This cohort study included a random sample of pregnant women who attended first trimester Down syndrome screening between January and October 2007 and had their results analysed by Pathology North, a state-wide public screening service in New South Wales, Australia. For this study, archived serum samples were thawed and analysed for SF (μg/l), sTfR (nmol/l) and CRP (mg/dl). SF was measured using a solid-phase direct sandwich enzyme-linked immunosorbent assay (ELISA) method (Calbiotech, Inc., Spring Valley, CA, USA) with an inter-assay coefficient of variation of 6.2%. sTfR concentrations were measured using an ELISA (Quantikine IVD, Human sTfR Immunoassay, R & D Systems, Minneapolis, MN, USA) with an inter-assay coefficient of variation of 6.4%. TBI (mg/kg) was calculated using the formula: − (log10 (sTfR/ferritin) − 2.8229)/0. 1207. 5, 8 Positive values of TBI represent storage iron and negative values indicate a deficient iron supply to peripheral tissues. 8 CRP was measured using the quantitative sandwich enzyme immunoassay technique (Quantikine) with an inter-assay coefficient of variation of 13.3%. Three established definitions for ID were used: SFo12 μg/l, 2 TfR ⩾ 21.0 nmol/l, according to the manufacturer's guidelines, 14 and TBIo0 mg/kg. 5, 8 In addition, SF concentration 470 μg/l was used to define iron-replete women with adequate iron reserves to meet the estimated iron requirement of pregnancy. 15 
Data sources
The laboratory database provided data on maternal body weight and gestational age at the time of screening. Information from the laboratory database and biomarker concentrations analysed using each woman's serum were linked to birth and hospital records. Birth data were sourced from the NSW Perinatal Data Collection (PDC) and hospitalization data from the NSW Admitted Patients Data Collection (APDC). The PDC is a statutory population-based collection of all births in NSW of at least 400-g birth weight or at least 20 weeks of gestation and includes information on maternal characteristics, pregnancy, labour, delivery and infant outcomes at birth. The APDC is a census of all admissions in NSW public and private hospitals. Up to 50 diagnosis and procedures for each separation are coded according to the tenth revision of the International Classification of Diseases, Australian Modification. 16 The NSW Centre for Health Record Linkage (CHeReL) performed probabilistic record linkage. 17 The CHeReL assesses linkage quality and for this study reported o5/1000 missed links and o 2/1000 false positive links. Only de-identified data were provided to the researchers. The study was approved by the NSW Population and Health Services Research Ethics Committee.
Only maternal, pregnancy and obstetric factors known to be reliably reported in birth and/or hospital data were included in the analysis. 18, 19 Explanatory variables included maternal age, parity, smoking during pregnancy and type of hospital (private versus public). Postcode was used to derive an indicator of socioeconomic status (SES). An Index of Relative Disadvantage produced by the Australian Bureau of Statistics was assigned to each postcode and women in the lowest 20th percentile were classified as disadvantaged. 20 Pregnancy outcomes included gestational diabetes mellitus (GDM), hypertensive disorders in pregnancy, postpartum haemorrhage, stillbirth, preterm birth, infant birthweight, small for gestational age, large for gestational age (LGA) and infant admission to neonatal intensive or special care unit. GDM was identified from hospital data based on diagnosis by the attending clinician. 19, 21, 22 Hypertensive disorders in pregnancy included women with the onset of hypertension from 20 weeks, including gestational hypertension, preeclampsia and eclampsia. 23 Postpartum haemorrhage was defined as blood loss of ⩾ 500 ml following vaginal birth or ⩾ 750 ml following caesarean section 19 and where a diagnosis of postpartum haemorrhage was recorded in the medical record. Stillbirth (in utero fetal death after 20 weeks of gestation), preterm birth (o37 weeks gestation), infant birth weight and infant admission to a neonatal intensive or special care unit were identified from PDC data. Small for gestational age and LGA were defined, respectively, as those infants in the o10th percentile and 490th percentile birth weight distribution for gestational age and infant sex. 24 
Statistical analysis
The prevalence of ID was calculated using established definitions for ferritin, sTfR and TBI. The concentrations of these nonparametric iron biomarkers including and then excluding women with elevated CRP (495th centile, 40.5 mg/dl) are described using the median and 25 and 75th percentiles. Univariate analysis were performed to examine the association between maternal characteristics and pregnancy and birth outcomes with each of the three definitions of ID, using ferritin, sTfR and TBI, using Chi-squared (X 2 ) test, or in the case of small cell sizes, Fisher's exact test. Multivariate logistic regression analysis was performed to account for potential confounders. Using backward stepwise selection, variables with least significance were progressively dropped from each model until all remaining covariates were statistically significant (two-tailed Po0.05). Variables not selected were then added back into the selected model, one at a time to assess whether they were confounders (that is, changed the effect by 410%), and final model was determined. Statistical analysis was performed using SAS for Windows version 9.3 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Sample characteristics
A total of 4420 women were included in the analysis after excluding 122 women with a twin pregnancy, medical abortion, infant with a major congenital anomaly or an undetectable ferritin and sTfR concentration. The mean (± s.d.) age of women was 32.2 ( ±4.9) years (8.0% o25 years), 36.5% were birthed in private hospitals and 35.8% of women were classified as disadvantaged. Nearly half (51.5%) of the women were nulliparous and 5.8% smoked during pregnancy. At the time of testing, mean (± s.d.) gestational age was 12.0 ( ±1.0) weeks and 50.8% were at 10-12 weeks of gestation. The mean (± s.d.) maternal body weight at the time of testing was 67.0 ( ±14.4) kg and maternal body weight in the ⩾ 75th percentile was defined as ⩾ 73 kg.
Prevalence and risk factors of ID The prevalence of ID based on ferritin, sTfR and TBI measures was 19.6, 15.3 and 15.7%, respectively (Table 1) . A small proportion of women (15.3%) were defined as ID using all three iron parameters. Of the 4006 women with detectable CRP values, 65.3% had CRP levels 40.5 mg/dl, an indication of inflammation. When women with CRP40.5 mg/dl were excluded, there were moderate changes in the prevalence of ID (Table 1) . Excluding women with elevated CRP levels, only 9.7% of women (n = 234/2407) had SF470 μg/l, indicating adequate iron reserves to meet the increased iron requirements of pregnancy. For pregnancy and birth outcomes, ID defined using SF or TBI was significantly associated with decreased odds of GDM and increased odds of LGA infants (Table 2) . Women with hypertensive disorders in pregnancy were more likely to have high sTfR ID in early pregnancy (Table 2 ). Multivariate analyses found that early pregnancy ID defined using SF or TBI remained significantly associated with reduced odds of GDM (AOR 0.43; 95% CI 0.23, 0.78 and AOR 0.39; 95% CI 0.20, 0.78, respectively; Table 3 ). None of the other covariates remained in final models except for CRP levels, which was positively associated with GDM for ID defined using SF (AOR 1.32; 95% CI 1.11, 1.57) and TBI (AOR 1.34; 95% CI 1.13, 1.59).
ID defined using TBI (AOR 1.38; 95% CI 1.03, 1.85) but not SF (AOR 1.25; 95% CI 0.95, 1.65) remained significantly associated with increased odds of LGA infants. In the final model or ID defined using TBI and LGA, increased maternal weight 
DISCUSSION
Results indicate that up to one in five Australian women enter pregnancy with ID, and only 11% begin pregnancy with sufficient iron stores to meet the total estimated iron requirements of pregnancy. The prevalence and risk factors of ID varied depending on which iron parameter was used to define ID. Depleted iron stores, as defined by low SF, occurred in 20% of women and were associated with being younger, multiparous and more socioeconomically disadvantaged. The prevalence of ID using sTfR and TBI were both around 15% and associated with high maternal body weight, multiparity and inflammation. In terms of the consequences of maternal ID, this study found that women with first trimester ID were less likely to develop GDM and more likely to have LGA infants, based on the iron parameters SF and TBI but not sTfR.
There are no data from Australian studies reporting on the prevalence of ID in pregnant women with which to compare our results. The prevalence of ID in pregnant women varies worldwide from 25% to 490%, 25-27 depending on the study population and iron supplement practices. Similar to the current study, others have found differences in the prevalence and risk factors for ID depending on which iron measure is used to define ID. 7, [27] [28] [29] [30] The present study found that 15.3% of women were defined as ID using all three definitions. Although the three iron indicators showed relatively good agreement for ID prevalence and Ferritin concentrations reflect decreased storage iron but are insensitive to further change during severe ID or negative iron balance. 5 sTfR concentrations reflect functional tissue ID and generally begin to change only after iron stores (in the form of ferritin) are depleted.
5 sTfR is also elevated by ineffective erythropoiesis.
14 Most women with ID based on sTfR levels (70%) had adequate iron stores (SF levels ⩾ 12 μg/l), possibly indicating impaired erythropoietin production as a result of an immune response by inflammatory cytokines 31 rather than inadequate iron nutrition.
Multivariate analyses found women with ID based on SF and TBI concentrations were more likely to be younger, multiparous and socioeconomically disadvantaged. These risk factors of ID have previously been reported elsewhere. 9, 27, 30 Multiparity may reflect depleted iron supply with increasing pregnancies, while younger age and low SES are thought to reflect poorer diets and lower intake of dietary iron and supplements. For women with ID defined using sTfR, multiparity and low SES were also risk factors. However, these women were also more likely to be heavier and have high CRP concentrations. Postulated explanations for the association between greater maternal weight, a marker of obesity and ID include dilutional hypoferremia, poor dietary iron intake, increased iron requirements, and/or impaired iron absorption in obese individuals. 32 There is also recent evidence that obesity-related inflammation may have a role through its regulation of hepcidin, such that iron absorption is reduced. 32 In terms of pregnancy and birth outcomes, our study did not detect a significant association between ID and preterm birth or small-for-gestational-age infants. Previous literature on the association between ID and these pregnancy outcomes is inconsistent, 12, 13, 33 with some reporting no association between ID and preterm birth, 11 while others have found an association with low ferritin. 34, 35 Inconsistencies in the literature may be explained by studies conducted in high-risk or different populations and/or settings and lack of adjustment for important confounders such as body weight and low-grade inflammation in analyses.
Women with ID defined using SF and TBI were less likely to develop subsequent GDM. These findings confirm those by Lao and Ho, 36 who in a retrospective study of 242 pregnant women with ID found that women with ID anaemia were less likely to have GDM (AOR: 0.46; 95% CI: 0.23, 0.90) after adjusting for multiparity and BMI ⩾ 25 kg/m 2 . Women with ID anaemia had significantly lower gestational weight gain throughout pregnancy, which the authors interpreted as suggestive of lower dietary energy and iron intakes. One of the limitations of the study by Lao and Ho 36 is the lack of data on inflammatory biomarkers. In our study, increased CRP levels, suggestive of increased inflammation, were significantly associated with increased odds of GDM. GDM is increasingly being recognized as an inflammatory condition that involves unbalanced inflammatory cytokine production. 37 An important component of innate immunity during infection and inflammation is redistribution of iron, whereby iron is shifted from the circulation into cellular stores to decrease iron bioavailability to invading microorganisms. 38 Being iron deficient may offer some advantage in that less iron is available to invading pathogens. Redistribution of iron from the circulation into cellular stores may explain why an association with GDM was only found for SF and TBI and not sTfR. It is uncertain whether elevated SF concentrations reflect excess iron or inflammation and further studies are needed to elucidate this pathway.
The finding that ID was associated with increased risk of LGA is also consistent with Lao et al. 39 We found excessive maternal body weight but not CRP levels to be associated with LGA, suggesting that the previously stated explanations for the association between ID and obesity, poor dietary iron intake or impaired iron absorption in obese individuals may be contributing. 32 It could also be that CRP levels were not associated with having an LGA infant because they were measured early in pregnancy. It is possible that CRP levels may have changed later in pregnancy and showed evidence of inflammation. It is also possible that women in our study with first trimester ID were diagnosed at their first antenatal booking and recommended to take iron supplements. A recent systematic review and metaanalysis of iron supplement use in pregnancy found that a daily dose of iron was associated with a significant increase in birth weight and decrease in risk of low birth weight. 33 However, without information on iron supplement use or the iron status of these women later in pregnancy, it is uncertain whether improved maternal iron status led to increased risk of LGA infants among these women.
Strengths of this study are the large population-based cohort design with thorough measurement, high ascertainment and reporting of first trimester iron status and pregnancy and birth outcomes and examination of a combination of biomarkers of ID, which provide information on different stages of ID. Limitations include lack of data on iron supplement use, maternal diet, maternal insulin and glucose concentrations and infant iron status. A notable limitation is the lack of data on maternal anaemia. Data from previous studies suggest that increased haemoglobin is associated with increased risk of glucose intolerance, diabetes and GDM, [40] [41] [42] and one study which found no difference in the incidence of GDM between anaemic and non-anaemic women found women with ID anaemia had about one-half the incidence of GDM compared with non-anaemic women. 43 The relationship between anaemia and GDM is not well understood and requires further study. A notable study limitation is the lack of assay standardization for sTfR. Quantification of sTfR is obtained from immunological methods such as ELISA, immunonephelometry and immunoturbidimetry. Values obtained from different methods are not comparable, which is a limitation of sTfR data. 44 The TBI prediction equation was developed using sTfR data obtained with an in-house ELISA developed by Flowers et al., 45 which served as the basis for the development of the Ramco assay and may not be directly applicable to studies using sTfR data measured with other types of assays. Although the present study used an ELISA assay to obtain sTfR values, use of a different ELISA kit to the one used by Flowers et al. 45 to establish the body iron model may have influenced the body iron values obtained in the present study.
In conclusion, a significant proportion of women experience early pregnancy ID reinforcing the importance of routine screening of pregnant women for anaemia and performing iron studies among those suspected of ID. More research is needed to understand how to best interpret information from multiple iron measurements taking into consideration the complex changes that occur in these concentrations during pregnancy. The association between ID and decreased risk of GDM and increased risk of LGA requires further examination in other study populations.
